Email Post: 15-Hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E(2) inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins.